News

Donna Schelby Named as CEO of Innovative Research, Inc.
We are pleased to announce that Donna Schelby has been named as CEO of Innovative Research, Inc. effective immediately. Donna joined our Innovative team two years ago as the VP of Operations and was a key figure in overseeing the recent acquisition of Molecular Innovations, Inc.

Read more →


Innovative Research, Inc. Acquires Molecular Innovations, Inc.
Innovative Research, Inc. has finalized its agreement to acquire Molecular Innovations, Inc. Headquarters will be maintained in Novi, MI and Innovative Research will continue to provide reliable reagents to clients both domestic and International.

Read more →


And the winner is...

In late 2019 Innovative Research, Inc. initiated a $10,000 grant opportunity within the life sciences field offering $2,500 in product credit and $7,500 in unrestricted funds. The response was inspiring with dozens of entries. 

Read more →


NEW! Synthetic CSF Now Available
Synthetic CSF from Innovative Research is immediately available and is more cost-effective per ml as compared to single donor and pooled human CSF options. Custom formulations & bulk volumes are also available, get in touch with our team for details and to secure your supply chain today!

Read more →


ASSURED FLOW SOLUTIONS PARTNERS WITH INNOVATIVE RESEARCH TO DEVELOP TEST KITS TO HELP IN COVID-19 FIGHT

HOUSTON—10 April 2020 Assured Flow Solutions (AFS) is teaming up with Innovative Research, Inc (Novi MI) to help with the critical task of developing an ELISA based test kit. The kit will determine whether an individual carries antibodies against SARS-CoV-2, the novel coronavirus that causes the illness COVID-19. AFS has provided a grant to Innovative Research, Inc to assist in the rapid development, validation, and distribution of these testing kits. The ability to detect the presence of specific antibodies against the novel coronavirus in individuals is of critical importance to ongoing research and could help to accomplish goals such as:...

Read more →



×